The Warren Center for Neuroscience Drug Discovery advances innovative small-molecule therapeutics from early discovery through preclinical development. Our multidisciplinary teams integrate biology, chemistry, pharmacology, and translational expertise to accelerate the progression of novel drug candidates across multiple target classes and disease areas.

Our pipeline reflects a diverse portfolio of programs spanning hit-to-lead, lead optimization, and candidate selection. Each project is supported by state-of-the-art technologies, rigorous scientific validation, and strategic collaborations that help move promising discoveries toward the clinic.